OraLiva awarded $1.9M National Institute of Dental and Craniofacial Research (NIDCR at NIH) Direct to Phase II SBIR grant for AI-linked cytomics-on-a-chip Read More
OraLiva helps general dentists and hygienists detect oral cancer and dysplasia early, during routine hygiene or recall visits.
OraLiva makes oral cancer screening straightforward for general dentists. Below is how it fits into a typical patient visit, from sample collection to secure digital reporting
OraLiva’s soft brush gently collects epithelial cells from suspicious lesions. The procedure takes under two minutes, causes no discomfort, and integrates easily into your workflow.
Samples are analyzed by our lab using OraLiva’s ONC In-CYT platform. Deep-learning technology, trained on over 13 million cell images, detects and classifies dysplasia (pre-cancer) with 97% accuracy.
Receive a detailed digital report with a clear numerical risk score and an actionable recommendation directly to your secure portal within two weeks.
General dentists choose OraLiva because it fits the realities of daily practice.
The procedure is painless, quick to perform, and easy to delegate, without changing appointment flow or requiring new equipment. The sample can be collected by dentists, hygienists or dental assistants.
Results arrive fast, reporting is clear, and reimbursement is straightforward. It’s a practical way to offer more advanced care, without adding complexity.
Interested in using OraLiva in your practice? Complete the form and our team will reach out with details..
Join the OraLiva wait list for product launch news and insights designed to support your team and improve early cancer detection in everyday care.
Join OraLiva's Waitlist
